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Abstract
Background: High radiation doses employed in cardiac imaging may increase cancer frequency in exposed patients after
decades. The aim of this study was to evaluate the relative trends in medical radiation exposure in a population hospitalized
for cardiovascular disease.
Methods and Results: An observational single-center study was conducted to examine 16,431 consecutive patients with
heart disease admitted to the Italian National Research Council Institute of Clinical Physiology between January 1970 and
December 2009. In all patients, the cumulative estimated effective dose was obtained from data mining of electronic
records of hospital admissions, adopting the effective dose typical values of the American Heart Association 2009 statement
and Mettler’s 2008 catalog of doses. Cumulative estimated effective dose per patient in the last 5 years was 22 (12–42) mSv
(median, 25th–75th percentiles), with higher values in ischemic heart disease (IHD), 37 (20–59) vs non-IHD, 13 (8–22) mSv,
p,0.001. Trends in radiation exposure showed a steady increase in IHD and a flat trend in non-IHD patients, with variation
from 1970–74 to 2005–2009 of +155% for IHD (p,0.001) and 21% in non-IHD (NS). The relative contribution of different
imaging techniques was remodeled over time, with nuclear cardiology dominating in 1970s (23% of individual exposure)
and invasive fluoroscopy in the last decade (90% of individual exposure).
Conclusion: A progressive increase in cumulative estimated effective dose is observed in hospitalized IHD patients. The
growing medical radiation exposure may encourage a more careful justification policy regarding ionizing imaging in
cardiology patients applying the two main principles of radiation protection: appropriate justification for ordering and
performing each procedure, and careful optimization of the radiation dose used during each procedure.
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Introduction
Rates of death from cardiovascular disease have been steadily
declining over the past few decades, with improvements observed
across most age and sex groups [1]. These improvements in
prognosis of cardiovascular patients are largely due to reduction in
major risk factors [2] and to the diffusion of medical diagnostic
and therapeutic procedures such as coronary angiography and
percutaneous coronary interventions for acute coronary syndrome
(ACS) [3]. At the same time, these types of exams expose patients
to ionizing radiation, which may elevate a person’s lifetime risk of
developing cancer [4]. Public and governmental awareness of
environmental influences on cancer risk has increased substantially
in recent years. Medical imaging has been identified as one of the
major causes of environmental exposure to carcinogens [5]. The
collective radiation dose from medical imaging has increased by
a factor of 6 in the last 2 decades [5,6], and cardiac imaging has
contributed greatly to this radiological warming [7–9]. Therefore,
it has been recently proposed that efforts should be made to
document effective total estimated effective dose per episode of
care or per disease or during lifetime [10]. Total estimated
effective dose can be a potential safety metric for patients with
common clinical conditions [11].
The current study hypothesis was that the cumulative in-
hospital radiological exposure increased significantly in adult
cardiology patients over the last few decades and more so in
patients with ischemic heart disease (IHD). The aim of this study
was to evaluate relative trends in cumulative estimated effective
dose to medical imaging radiological examinations in a population
hospitalized for cardiovascular disease.
Materials and Methods
Ethics Statement
The study was approved by the Pisa Ethical Committee as a part
(workpackage 1) of the SUIT-Heart (Stop Useless Ionizing Testing
in Heart Disease) study on October 1, 2010 (Study Protocol nu
3005/2010). Written consent was given by the patients at the time
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of admission to the hospital for their information to be stored in
the hospital database and used for research.
Study Population
The study included 16,431 consecutive patients hospitalized at
the Italian National Research Council (CNR) Institute of Clinical
Physiology between January 1970 and December 2009 due to
suspected or documented cardiac disease. At discharge, all
demographic, history, clinical and instrumental data were
collected in the Institute’s dedicated cardiovascular database
[12,13]. For this study, data on diagnosis, nuclear medicine and
radiological cardiac imaging tests were considered.
Dose Estimation
For each radiation test, the representative effective dose was
estimated in milliSievert (mSv) and also with corresponding dose
in multiples of chest X-rays (single postero-anterior projection,
0.02 mSv) as recommended by European Commission Medical
Imaging guidelines [14], and by the UK Royal College of
Radiology guidelines [15). Reference doses were taken from four
sources: European [14]and UK [15] guidelines; from the
American Heart Association 2009 committee [16); and when not
listed elsewhere, from Mettler’s 2008 catalogue of doses of
common medical imaging testing (see Table 1) [17].
Statistical Analysis
Values are presented as mean 6 standard deviation (SD) or
median (25th–75th percentiles) for parameters with skewed
distribution as mSv. Chi-square test with Yates correction was
used to compare categorical data. The unpaired 2-tailed
Student’s t-test and the Mann-Whitney test were employed for
comparisons. A p-value of,0.05 was considered statistically
significant. SPSS (SPSS Inc., Chicago, IL, USA) version 13 was
used for all analyses.
Results
Study Population
The characteristics of the population at study entry are shown in
Table 2. IHD was defined in 63% of patients as history of
myocardial infarction, and/or angiographic documentation of
significant coronary stenosis and/or chest pain syndrome in spite
of angiographically normal coronary arteries (syndrome X or
coronary vasospastic angina) or atypical chest pain eventually
defined of proven ischemic origin. Non-IHD patients were patients
affected by valvular and pericardial disease, cardiomyopathy, non
ischemic arrhythmias etc. Traditional risk factors were present in
almost 50% of the population. Sixty-eight percent of patients
underwent at least one angiographic procedure, and 24% at least
one myocardial nuclear medicine scan.
Radiological Exposures
The most frequent examinations were coronary angiography,
percutaneous coronary interventions, and Thallium and Sestamibi
scan for myocardial perfusion imaging (Table 2). Males received
a significantly higher dose exposure than females (20, 12–42 vs 13,
7–28 mSv, p,0.001).IHD patients received a significant higher
dose exposure than non-IHD patients (27, 12–49 vs 12, 4–19,
p,0. 0001).
Radiological Exposure Over Time
The trends in radiation exposure expressed as cumulative
estimated effective dose showed a steady increase in IHD and a flat
trend in non-IHD patients, with variation from 1970–74 to 2005–
2009 of +155% for IHD (p,0.001) and 21% in non-IHD (NS)
(Figure 1). The relative contribution of different imaging
techniques was also remodeled over time, with nuclear cardiology
(mostly cardiac perfusion scintigraphy) dominating in 1970s (23%
of individual exposure) and invasive fluoroscopy (mostly contrast
left ventriculography and coronary angiography) and interven-




Multiples of chest X-ray
(PA projection) Ref.
Chest X-ray PA 0.02 1 14,15
Chest CT 8 400 14,15
Abdomen CT 10 500 14,15
64-Slice coronary CTA without tube current modulation 15 750 16
64-Slice coronary CTA with tube current modulation 9 450 16
Diagnostic invasive coronary angiogram 7 350 16
Abdominal angiography or aortography 12 600 16
Percutaneous coronary intervention 15 750 16
Radiofrequency ablation 15 750 16
Sestamibi (1-day) stress-test MPS 9 450 16
Thallium stress-rest MPS 41 2050 16
F-18 FDG 14 700 16
Cardiac ventriculography (99mTc-labeled red blood cells) 7.8 390 17
Lung perfusion (99mTc-MAA) 2 100 17
Gallium-67 citrate 15 750 17
PA: postero-anterior. CT: computed tomography. CTA: coronary computed tomography angiography. MPS: myocardial perfusion scan. FDG: fluorodeoxyglucose. MAA:
macroaggregated albumin.
doi:10.1371/journal.pone.0050168.t001
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tional fluoroscopy (mostly percutaneous coronary revasculariza-
tion) in the last decade (90% of individual exposure).
Radiological Exposure and Acute Coronary Syndrome
In IHD patients a trend toward a progressive increase in
cumulative estimated effective dose was observed both in patients
hospitalized for ACS and in stable ischemic patients who received







Age (years) mean6SD 62613 62612 62615 0.450
Male sex, n (%) 11,348 (69) 8,125 (78) 3,223 (53) ,0.001
ACS, n (%) 3055(30)
STEMI/nSTEMI, n(%) 1,668(16)
Previous MI, n (%) 5,182(50)
Stable angina, n (%) 2,825(27)
Variant angina/Syndrome X/etc, n (%) 1,773(17)
Cardiomyopathy, n (%) 1,823 869 (8) 954(15)
Other (valvular and pericardial disease, etc), n (%) 4,355(42) 2,009 (19) 2,346(38) ,0.001
History of cigarette smoking, n (%) 7,797(47) 5,770(56) 2,027(33) ,0.001
Hypercholesterolemia, n.(%) 6,768 (41) 4,786 (46) 1,982 (33) ,0.001
Diabetes mellitus, n.(%) 2,885 (17) 2,060 (20) 825 (14) ,0.001
Hypertension, n.(%) 7,446 (45) 4,631 (45) 2,815 (46) 0.054
Coronary angiographies, n (%); 13,604 (82) 10,977(106) 2,627(43) ,0.001
PCIs, n (%) 5,353(52) ,0.001
Number of PCI treated vessels, n (%) 6,838 (66)
Thallium or Sestamibi scan, n (%) 3,918(24) 3,109 (30) 809 (13) ,.0001
Cumulative estimated effective dose mSv/pt (median, and
inter-quartile range)
17(12–38) 27(12–49) 12(4–19) ,.0001
MI: myocardial infarction. PCI: percutaneous coronary intervention. STEMI: ST Elevation Myocardial Infarction. nSTEMI: non ST Elevation Myocardial Infarction.
doi:10.1371/journal.pone.0050168.t002
Figure 1. Secular trends of cardiovascular medical radiation exposure over the last 40 years in in-hospital patients admitted for
cardiovascular disease. Radiation exposure is expressed as cumulative estimated effective dose/patient. On the left panel the trend of non-
ischemic (non-IHD) patients, and on the right the one of ischemic (IHD) patients.
doi:10.1371/journal.pone.0050168.g001
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a significantly higher dose (23, 12–47 vs 27, 12–51 mSv, p,0.001)
(Figure2).
Discussion
In the last four decades, we observed a steady increase in
medical cumulative estimated effective dose in our cardiology
patients. This increase was limited to patients with IHD.
Comparison with Previous Studies
The observed cumulative estimated effective dose trends in our
cohort closely mirror overall worldwide trends referring to any
kind of medical exposure in citizens of the most affluent countries
[17,18]. This is not surprising, since cardiac imaging is the major
source of medical radiation of contemporary patients, accounting
for 85% of all nuclear cardiology exposures in the US [18],
although this percentage shows substantial geographic heteroge-
neity [19].The medical radiation exposure profile of the contem-
porary patient is also consistent with previous evidence suggesting
that in adult cardiology patients invasive fluoroscopy accounts for
12% of all examinations, and 48% of the total collective dose [7] of
population presented with coronary heart disease. It is also
interesting to observe the effects of evolution of medical technology
on the temporal trends. In our institute, nuclear medicine started
in the 1970s. At the beginning, this innovation led to extensive
application for cardiac imaging of left ventricular function (with
radionuclide ventriculography) and myocardial perfusion (with
Thallium imaging) [20]. The relative decrease of the nuclear
medicine contribution in the last decade is due to the development
of transthoracic 2-dimensional echocardiography (in the 1980s)
and stress echocardiography (1990s), somewhat reducing the
applications of myocardial scintigraphy in in-hospital patients
[21]. Another source of reduction is the progressive shift of
radionuclide tracer from Thallium (100% of all exams in the
seventies) to Sestamibi, which has a significantly lower radiation
dose [22] and accounted for 95% of all myocardial perfusion
imaging examinations in the last 5 years and 100% in the last 3
years. In fact, starting July 2007 our nuclear cardiology officially
embargoed Thallium studies for dosimetric reasons.
Limitations
Our work was retrospective and observational, with the
inherent limitations of this study design. However, over the years
our data bank has generated very robust information and has
intrinsic merit, since for 40 years all in-hospital patients have been
followed-up by the coordinated efforts of technicians, statisticians,
and physicians, and all diagnostic and therapeutic procedures
carefully collected and stored at the time of admission [12,13].
The radiological history was derived from hospital records, and
reference doses, not truly delivered doses, were considered.
Reference doses are neither precisely measured nor subject-
specific [23] and can vary on the basis of the literature used as
reference [24,16].
The effective dose is a calculated estimate designed to provide
a sex-averaged dose for a reference subject in a given exposure
situation, not a dose for a specific subject [25]. This calculation
relies on assumptions regarding the radiation sensitivity of organs
and tissues, imaging techniques and protocols, and, in the case of
nuclear imaging, radiopharmaceutical activity, half-life, distribu-
tion, and elimination kinetics [25]. Although these assumptions
have raised controversy concerning the use of effective dose [26–
30] it remains the only measure currently available that reflects the
overall potential biologic detriment among various types of
radiation exposure, which is why we used it as our primary
measure of radiation exposure.
There is, in practice, marked dose variability for each exam.
The variability is highest for interventional procedures. For
example, a coronary stenting procedure is associated with an
average effective dose corresponding to 15 mSv, but the individual
procedure value may range anywhere between 7 and 57 mSv
Figure 2. Secular trends of cardiovascular medical radiation exposure over the last 40 years in ischemic (IHD) patients. Radiation
exposure is expressed as cumulative estimated effective dose/patient. On the left panel, trend of chronic angina patients (Non-ACS), and on the right
trend of acute coronary syndrome (ACS) patients.
doi:10.1371/journal.pone.0050168.g002
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according to guidelines [16], and even from 3 mSv to 80 mSv in
a consecutive series of real patients studied in a high volume cath
lab [31,32]. A similar variation has been associated with non-
invasive examinations. For example, examining CT studies
performed on adult patients within and across several institutions
in the San Francisco Bay area, Smith-Bindman et al. report
a mean 13-fold variation in dose indexes between the highest and
the lowest dose for each type of study assessed [33]. It is almost
certain that the doses of some examinations – especially invasive
intervention–have changed substantially over the years, with the
evolution of technology, greater experience with the technique,
and the diffusion of the culture of radioprotection [34]. Neverthe-
less, the number of examinations can be considered a reasonably
good proxy for radiation exposure, and the cumulative estimated
effective dose per patient is likely to give a reliable estimate of the
relative irradiation burden within the cohort, rather than precise
absolute values, which are likely to be systematically under-
estimated. As a further limitation, as this data set involves inpatient
examinations only, it underestimates total exposure contributed by
outpatient testing (especially CT imaging in the current era) and
cumulative exposure from subsequent testing over the course of
time from both cardiac and non-cardiac diagnostic procedures.
Clinical Implications
The prognosis of cardiac patients has changed spectacularly
over the last 40 years, thanks to reduction in major risk factors and
breakthrough advances in cardiac imaging, pharmacological
therapy, cardiac surgery, and interventional cardiology [2,3].
The cardiac patient lives longer and better and this is also
witnessed by the relative low rate of cardiac death in contempo-
rary in-hospital population. However, this also means that we
should pay greater attention to long-term side effects of our
interventions, including imaging procedures using ionizing radi-
ation. These types of imaging procedures have led to improve-
ments in the diagnosis and treatment of numerous cardiological
diseases. At the same time, these types of exams expose patients to
ionizing radiation, which is a known carcinogen, and a single
interventional procedure is associated with increased chromosome
aberration in circulating lymphocytes, which are an intermediate
endpoint and a long-term predictor of cancer [35]. The
contemporary cardiology patient receives a cumulative median
effective dose of 60 mSv per head, with 1 out of 4 patients
exceeding 100 mSv [7]. This refers to a cumulative, lifetime
exposure, with all intra- and out-of-hospital examinations, whereas
in the present study only in-hospital exposures are considered. In
the United States, high doses (.20–50 mSV/year) from medical
imaging procedures were incurred in 2% of the general population
[36]. Unfortunately, one-third of our (ionizing and non-ionizing)
cardiac imaging exams are partially or totally inappropriate
[37,38]. In our population a significantly higher estimated effective
dose was observed in stable ischemic patients in whom the
beneficial effect of invasive procedure is less proven [2].We should
make every effort to reduce this unnecessary exposure, applying
the two main principles of radiation protection: appropriate
justification for ordering and performing each procedure, and
careful optimization of the radiation dose used during each
procedure [39,40]. In other words, we as cardiologists should be
proactive in implementing in our practice the recommendations of
the FDA [4]: ‘‘Each patient should get the right exam at the right
time, with the right radiation dose’’.
Conclusions
A trend to progressive increase in cumulative estimated effective
dose is observed in a hospitalized population of cardiovascular
patients with IHD, mainly due to extensive use of serial
myocardial scintigraphies and invasive fluoroscopy procedures.
The increase in radiation exposure is much less marked in patients
with non-ischemic heart disease, such as cardiomyopathy, valvular
or pericardial disease. This high and rising radiation exposure may
further increase in the era of cardiac CT. The growing medical
radiation exposure may encourage a more careful justification and
optimization policy regarding ionizing imaging in cardiologic
patients, often now belonging to a low risk group with benign
prognosis and long life expectancy, which should make both the
doctors and the patients more conscious of long-term, adverse,
potential cancer effects of radiation use.
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